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Abstract
Like many Gram-negative pathogens, Shigella rely on a type three secretion system
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(T3SS) for injection of effector proteins directly into eukaryotic host cells to initiate
and sustain infection. Protein secretion through the needle-like type three secretion
apparatus (T3SA) requires ATP hydrolysis by the T3SS ATPase Spa47, making it a
likely target for in vivo regulation of T3SS activity and an attractive target for
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small molecule therapeutics against shigellosis. Here, we developed a model of an
activated Spa47 homo-hexamer, identifying two distinct regions at each protomer
interface that we hypothesized to provide intermolecular interactions supporting
Spa47 oligomerization and enzymatic activation. Mutational analysis and a series
of high-resolution crystal structures confirm the importance of these residues, as
many of the engineered mutants are unable to form oligomers and efficiently
hydrolyze ATP in vitro. Furthermore, in vivo evaluation of Shigella virulence phenotype uncovered a strong correlation between T3SS effector protein secretion,
host cell membrane disruption, and cellular invasion by the tested mutant strains,
suggesting that perturbation of the identified interfacial residues/interactions
influences Spa47 activity through preventing oligomer formation, which in turn
regulates Shigella virulence. The most impactful mutations are observed within
the conserved Site 2 interface where the native residues support oligomerization
and likely contribute to a complex hydrogen bonding network that organizes the
active site and supports catalysis. The critical reliance on these conserved residues suggests that aspects of T3SS regulation may also be conserved, providing
promise for the development of a cross-species therapeutic that broadly targets
T3SS ATPase oligomerization and activation.
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Here, we use a recently solved Spa47 crystal structure15 to develop

1 | I N T RO D UC T I O N

a homo-hexameric model of the activated Spa47 complex and identify
Shigella is a genus of nonmotile, facultative anaerobic, Gram-negative

interfacial residues that are involved in Spa47 oligomerization. The

bacteria belonging to the family Enterobacteriaceae. Infection by any

identified residues cluster to two independent sites at the interface

one of the four Shigella species results in shigellosis, a severe form of

between Spa47 protomers where they appear to be involved in a com-

bacillary dysentery hallmarked by colonic mucosal inflammation and

plex hydrogen bonding network that supports Spa47 oligomerization

bloody diarrhea. The debilitating symptoms, low infectious dose
(10-100 organisms),1 and rapid emergence of antibiotic and multiantibiotic resistant strains result in an estimated 90 million annual
infections and more than 100 000 deaths per year, making Shigella a
worldwide health concern.2,3 The highest mortality rate, however, is
observed among children living in developing countries lacking access
to clean drinking water and proper medical care.4 With no FDA
approved vaccine against Shigella yet available, it is likely that without
active intervention, Shigella infections will continue to be one of the
leading bacterial causes of diarrheal disease and a significant global

and catalysis. Each of the identified residues was mutated to an oppositely charged amino acid as well as to alanine in an effort to disrupt
the predicted interactions. Indeed, several of the engineered mutations
had a significant negative influence on oligomer formation and enzyme
activity in vitro as well as T3SS activity and Shigella virulence phenotype in vivo. High-resolution crystal structures of ten of the Spa47
mutants verified the intended mutations and showed that the overall
integrity of the protein structure was unaffected, supporting our
hypothesis that the observed effects resulted from perturbed intermolecular interactions. Together, these findings begin to assemble an
important molecular description of Spa47 oligomerization and the influ-

health burden. These alarming factors underscore the urgent need to

ences it has on T3SS activity and Shigella virulence phenotype while

better understand the molecular mechanisms responsible for activa-

additionally identifying precise and highly-conserved targets for much

tion and regulation of Shigella's primary virulence factor, the type

needed anti-infective therapeutics against T3SS ATPases.

three secretion system (T3SS).
The T3SS is an elegant nanomachine shared by many Gramnegative bacteria, including Shigella, Salmonella, Escherichia coli, Chlamydia, Yersinia, and others.5-7 Each of these pathogens is reliant on
their T3SS(s) as a primary virulence factor that injects an arsenal of

2 | E X P ER I M E N T A L P R O C E D U R ES
2.1 | Materials

bacterial effector proteins directly into the host cell cytoplasm. While

Wild-type S. flexneri corresponds to the serotype 2a 2457T strain

the roles of the injected effector proteins are pathogen specific and

originally isolated in 1954.18 The S. flexneri spa47 null strain was

tailored to the pathogens' infective environments and replicative

engineered by Abdelmounaaïm Allaoui as described in Jouihri et al.19

niches, the effectors are all secreted through a highly conserved

E. coli strains and 2X ligation mix were from Novagen (Madison, WI).

needle-like type three secretion apparatus (T3SA) and generally sup-

Restriction enzymes, the pTYB21 protein expression plasmid, PCR

8

port host cell infection and evasion of host immune responses.

buffer, Phusion High-Fidelity polymerase, and chitin resin were pur-

Kubori and colleagues first visualized negative-stained structures of

chased from New England Biolabs (Ipswich, MA). Oligonucleotide

the T3SA via transmission electron microscopy (TEM) in 1998. These

primers and the synthesized spa47 gene were from Integrated DNA

original images and a more recent series of TEM and cryo-electron

Technologies (Coralville, IA). Defibrinated sheep blood was from Colo-

9

tomography 3D structures clearly show that the T3SA consists of a
basal body that anchors the apparatus to the bacterial inner and outer
membranes, a hollow needle-like structure that extends from the basal
body past the membrane-associated lipopolysaccharide (LPS) layer, and
an associated protein complex that resides at the tip of the needle and
penetrates the eukaryotic host cell membrane.10-13 Additionally, several
of the most recent studies show that the T3SA contains a cytoplasmic
protein complex associated with the apparatus basal body and that this
complex includes a highly conserved homooligomeric ATPase that supports protein secretion through the apparatus.10,14 We have previously

rado Serum Company (Denver, CO), and HeLa cells were from the
American Type Culture Collection (Manassas, VA). The Superdex
200 Increase size-exclusion column and 5 mL HiTrapQ resin were purchased from GE Healthcare (Pittsburgh, PA). ATP was from SigmaAldrich (St. Louis, MO) and α-32P-ATP was from Perkin Elmer (Boston,
MA). Dithiothreitol (DTT) and ampicillin were from Gold Biotechnology (St. Louis, MO). Rabbit anti-IpaC antibodies and the pWPsf4 plasmid were generous gifts from Wendy and William Picking (University
of Kansas). DyLight 488 conjugated mouse anti-glyceraldehyde
3-phosphate dehydrogenase and Alexa Fluor 647 goat anti-rabbit
antibodies were purchased from Thermo Scientific (Rockford, IL). All

demonstrated that the Shigella protein Spa47 is a T3SS ATPase whose

other solutions and chemicals were of reagent grade. The UniProtKB

activity is essential for protein secretion through the apparatus and

accession number for Spa47 is P0A1C1.

overall Shigella virulence.15,16 Furthermore, Spa47 oligomerization is
required for ATPase activity, as residues from opposite sides of adjacent Spa47 protomers contribute to interfacial active sites within the

2.2 | Cloning

complex, making Spa47 oligomerization a likely means of regulating

The spa47 gene was purchased as a double-stranded gBlock product

T3SS activity in vivo and an attractive target for nonantibiotic thera-

from Integrated DNA Technologies with modifications for cloning into

peutics against Shigella infections.17

the expression plasmid pTYB21, which encodes an N-terminal chitin
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binding domain (CBD) and intein linker as described previously.16 Each

4000, and 5.5% - 10.5% MPD. Small rod-like crystals were observed

of the Spa47 point mutants described in this study was generated in

after approximately eight hours at room temperature (20-22 C).

the expression plasmid pTYB21 using inverse PCR and the wild-type
spa47/pTYB21 construct as a template. Wild-type spa47 and each of
the tested mutants was additionally cloned into the plasmid pWPsf4
using primers that encode 5’ NdeI and 3’ BamHI restriction sites.

2.5 | Crystallographic data collection and structure
determination

Spa47 constructs lacking the N-terminal 79 residues were generated

Crystallographic data for each Spa47Δ1-79 point mutation variant were

using inverse PCR and the spa47 mutants in pTYB21 as a template.

collected on beamlines 9-2 and 14-1 at the Stanford Synchrotron

Primer sequences are available upon request. All constructs were

Radiation Lightsource. Data were processed using HKL2000.20 The

sequence verified by Sanger sequencing (Genewiz, Inc., South Plain-

crystals belong to space group P 21 and contain two molecules in

field, NJ).

the asymmetric unit (Matthews coefficient = 2.3, 45% solvent). The
structures were solved by molecular replacement using the published wild-type Spa47Δ1-79 structure (PDB ID 5SWJ) as the search

2.3 | Protein expression and purification

model. PHENIX21 was used to perform individual b-factor, posi-

Spa47 and each of the Spa47 mutants encoded in pTYB21 were

tional, and TLS refinement. Final refinement statistics are shown

transformed into E. coli Tuner (DE3) cells, expressed, and purified as

for each structure in Supplementary Table S1.

16

previously described.

Briefly, the transformed E. coli cells were grown

to an OD600 of 0.8 in Terrific Broth media containing 0.1 mg/mL ampicillin at 37 C, 200 RPM. The culture was cooled to 17 C and induced
with 1 mM IPTG for approximately 20 h (17 C, 200 RPM). All subse-

2.6 | Size-exclusion chromatography evaluation of
Spa47 oligomerization

quent steps were carried out at 4 C (or on ice) unless otherwise stated.

Wild-type Spa47 and each of the engineered Spa47 mutants were

The bacteria were pelleted by centrifugation, resuspended in binding

expressed and purified as described above. Spa47 was purified from

buffer (20 mM Tris, 500 mM NaCl, pH 7.9) containing 0.2 mM of the

one-liter cultures and concentrated to 1 mL prior to filtration to

protease inhibitor 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochlo-

remove any insoluble components, and the protein was then evalu-

ride (AEBSF), lysed by sonication, and purified using a chitin affinity col-

ated using a GE Superdex 200 16/600 size exclusion column. The col-

umn. The purified Spa47 protein was eluted using on-column cleavage

umn was preequilibrated with 20 mM Tris, 100 mM NaCl, 5 mM DTT,

of the intein linker domain by exposure to binding buffer containing

pH 7.9, and operated at 0.5 mL/min. A280 elution profiles were gener-

50 mM DTT. The elution fractions were diluted, resulting in a final

ated and used to visualize the distribution of monomeric and oligomeric

buffer concentration of 20 mM Tris, 100 mM NaCl, 5 mM DTT, pH 7.9,

species of the Spa47 proteins. The elution profiles were normalized to

supporting additional purification by anion exchange chromatography.

the maximum absorbance value for each of the constructs and baseline

Wild-type Spa47 and most of the purified mutants do not bind the

corrections, and smoothing functions were performed on each of the

anion exchange resin under these conditions, resulting in purified

chromatograms.

R271E

Spa47 in the flow through. Spa47

bound the anion exchange col-

umn tightly and was eluted using a 100 mM to 1 M NaCl elution gradient. The purified Spa47 was concentrated using Sartorius centrifugal

2.7 | Shigella invasion of epithelial cells

filter units with a 30 kDa molecular weight cutoff and further

Invasion phenotype of S. flexneri strains expressing the engineered

purified/characterized using a Superdex 200 16/600 size exclusion col-

Spa47 mutants were determined by a gentamicin protection assay as

umn equilibrated with 20 mM Tris, 100 mM NaCl, 5 mM DTT, pH 7.9

previously described.22 Sterile 24-well plates were seeded with pas-

followed by SDS-PAGE. Spa47 concentrations were determined using

saged HeLa cells and grown overnight in DMEM supplemented with

in gel densitometry of Coomassie stained acrylamide gels and bovine

10% fetal calf serum, penicillin, and streptomycin at 100% relative

serum albumin as a standard, as previously reported and validated.16 All

humidity, 37 C, and 5% CO2. Evaluated S. flexneri strains were streaked

Spa47 concentrations are reported in monomer concentration units for

onto tryptic soy agar (TSA) plates containing 0.025% Congo Red and

consistency and clarity.

grown overnight at 37 C. Small cultures containing appropriate antibiotics were inoculated from the agar plates and grown to and OD600 of
0.6 at 37 C and 200 rpm. Equivalent bacterial loads were introduced

2.4 | Spa47 crystallization

to the cultured HeLa cells, and the plates were centrifuged at 1000 × g

Crystallization of engineered Spa47Δ1-79 point mutation variants was

for 5 minutes to synchronize contact between the bacteria and HeLa

performed using standard vapor diffusion methods in conditions simi-

cells. The inoculated cells were incubated at 37 C for 30 minutes,

Δ1-79

con-

rinsed to remove extracellular bacteria, and treated with 50 μg/mL

struct.15 For each construct, drops containing 3 μL protein

gentamicin to selectively kill the Shigella that had not successfully

(10-20 mg/mL) and 1 μL well solution were set up by hanging drop

invaded the HeLa cells. The HeLa cells were then lysed with 1%

vapor diffusion with well conditions containing 0.1 M Tris pH 8.5,

agarose in water and overlaid with a LB agar solution. Overnight

0.2 M ammonium acetate, 0.2 M lithium sulfate, 20% - 26% PEG

incubation at 37 C resulted in Shigella colony formation from the

lar to those previously identified for the wild-type Spa47
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previously internalized bacteria, supporting a quantitative compari-

anti-IpaC rabbit polyclonal antibodies and an Alexa 647 goat anti-rabbit

son of invasion phenotype among the tested Shigella strains.

secondary antibody. Secreted IpaC levels were detected and compared
using a Bio-Rad ChemiDoc imaging system and the associated Image
Lab analysis software. As validated previously,26 a monoclonal antibody

2.8 | Shigella-induced erythrocyte hemolysis

against the cytoplasmic enzyme glyceraldehyde-3-phosphate dehydro-

The effects of the engineered Spa47 mutations on T3SS-mediated

genase (GAPDH) was used as a control in the Western blot to ensure

hemolysis of red blood cells were determined using a slightly modified

that the proteins observed in the supernatant were secreted from the

version of a previously described method.23 Briefly, S. flexneri

bacteria and were not the result of cell lysis.

expressing wild-type Spa47 or the Spa47 mutants described in this
study were grown overnight on TSA-Congo Red plates, and a small
number of isolated colonies were used to inoculate 10 mL of tryptic

2.10 | Spa47 ATP hydrolysis assay

soy broth containing appropriate antibiotics. The cultures were grown

A radioactive α-32P-ATP multiple time point activity assay was used to

to an OD600 of ~1.0, collected by centrifugation, and gently

determine reaction rates for all of the engineered Spa47 mutants in

resuspended in 200 μL PBS. Then 50 μL of each bacterial mix was com-

monomeric and oligomeric state. The assay was carried out as described

bined with 5 × 108 red blood cells in a 96-well microtiter plate and

previously.27 Briefly, the ATPase reactions were initiated at room temper-

centrifuged at 2300 × g for 15 minutes to initiate contact between the

ature (20-22 C) by combining protein samples with a prepared ATP solu-



bacteria and the red blood cells. The plate was then incubated at 37 C

tion resulting in a final concentration of 15 mM Tris (pH 7.9), 75 mM

for 1 hour and the bacteria/red blood cell mix was resuspended follow-

NaCl, 10 mM MgCl2, 1 mM cold ATP, and 0.5 μCi (300 nM) α-32P-ATP.



ing the addition of 100 μL of 4 C PBS. The resuspended mix was cen-

Samples were removed from the reaction mixture at defined time points

trifuged at 2300 × g and 10 C for 15 minutes to separate cellular

and the reactions rapidly quenched with a final concentration of 250 mM

components and the hemoglobin that was released following red blood

ethylenediaminetetraacetic acid (EDTA). The level of ATP hydrolysis at

cell lysis. The levels of released hemoglobin in the supernatant were

each time point was quantified by separating the unreacted α-32P-ATP

quantified by measuring absorbance at 545 nm and compared with the

substrate and the α-32P-ADP product by TLC followed by exposure to a

released hemoglobin levels resulting from S. flexneri expressing wild-

phosphor imaging screen and detection of 32P activity with a Storm Pho-

type Spa47.

sphorImager (Molecular Dynamics). The concentration of ADP formed
was quantified using ImageQuant software (Molecular Dynamics) and

2.9 | Quantitation of S. flexneri T3SS activation and
translocator secretion

plotted as a function of reaction time to provide a rate of ATP hydrolysis
for each enzyme under each condition tested. The final concentration of
Spa47 in all reaction conditions was held constant at 0.5 μM.

The small diazo dye Congo Red effectively induces secretion of
translocator proteins through the Shigella T3SS by mimicking the natural trigger resulting from host cell membrane interaction.24 Thus, Congo
Red exposure serves as a valuable tool that allows for concerted activation of T3SSs from Shigella strains expressing various protein mutants
such as the engineered Spa47 mutants used in this study. The Congo

3 | RESULTS
3.1 | Predicting intermolecular interactions essential
for Spa47 oligomerization and activation

Red secretion assay protocol has been described in detail elsewhere.25

An energy minimized model of an activated Spa47 homo-hexamer

Briefly, a S. flexneri strain lacking the gene for Spa47, a strain expressing

was generated by aligning the recently solved 2.15 Å Spa47K165A

wild-type Spa47, and strains expressing the engineered Spa47 mutants

structure (PDB ID 5SYP) to each of the protomers of the 2.8 Å

evaluated in this study were grown overnight on TSA-Congo Red plates

hetero-hexameric F1 α3β3 ATP synthase structure (PDB ID 1BMF)

and a small number of isolated colonies were used to inoculate 10 mL

using PyMOL,28 as described previously.15 The interfaces of adjoining

of tryptic soy broth containing appropriate antibiotics. Cultures were

Spa47 protomers within the model were manually searched for inter-



grown at 37 C to an OD600 of ~1.0 before they were cooled on ice to

actions that may be involved in supporting Spa47 oligomerization and

temporarily slow protein expression and secretion. The cultures were

activation. Two such sites were identified at each interface where res-

centrifuged and rinsed to separate bacteria from the culture superna-

idues from one protomer extend across the interface to potentially

tant and any effector proteins that had been secreted up to this point.

interact with oppositely charged amino acids from the adjacent proto-

The cells were then resuspended in sodium phosphate buffer con-

mer (Figure 1), driving and/or stabilizing homo-oligomerization and

taining 0.28 mg/mL Congo Red and were incubated at 37 C for 1 hour

activation of Spa47. For simplicity, the site containing R271, R272,

to promote active type three secretion. Cultures were then chilled on

and E267 that is located near the pore of the hexameric structure will

ice for 5 minutes to prevent further secretion and the bacteria were

be referred to as “Site 1” (Figure 1A) and the region containing R189,

separated from the protein-containing supernatant by centrifugation

R191, and E287 buried more deeply in the protomer interfaces and

at 13000 × g for 15 minutes at 4 C. The secreted proteins within

located near the active site will be referred to as “Site 2” (Figure 1B).

the supernatant from each strain were separated using SDS-PAGE,

A Clustal Omega sequence alignment of Spa47 and several related

transferred to PVDF membranes by Western blot, and probed using

T3SS ATPases identifies 100% conservation of all three Site 2 residues

DEMLER ET AL.
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F I G U R E 1 Energy minimized homo-hexameric Spa47 model predicts multiple intermolecular interactions critical for oligomerization and
activation. A, Spa47K165A (PDB: 5SYP) was modeled as an activated homo-hexamer, based on the hexameric F1 ATP synthase structure (PDB:
1BMF). Each Spa47 monomer subunit is colored independently, while residues in Site 1 are colored in green. The insert provides a closer view of
the Site 1 residues with E267 from one protomer and residues R271 and R272 from an adjacent protomer spanning the interface. B, The Spa47
homo-hexamer model is rotated down 90 and all but two of the protomers are removed for clarity. Site 2 residues within the remaining interface
are colored in yellow and a black star locates the approximate position of the interfacial active site. The insert shows a closer view of the residues
within Site 2 with R189 and R191 from one protomer directed across the interface toward E287 of the adjacent protomer. C, Protein sequence
alignment of several T3SS ATPases was performed using the Uniprot multiple sequence alignment tool, Clustal Omega, with single fully
conserved residues (*), conservation between groups with strongly similar properties (:), and weakly similar properties (.) identified. Alpha helix
and beta sheet regions, as predicted by the PSIPRED structure prediction server, are color coded red and blue, respectively. Predicted Walker A
(P-loop) and Walker B regions are identified, and the Site 1 and Site 2 residues targeted for mutation are identified using solid and dashed boxes,
respectively. Uniprot accession numbers used for sequence alignment are Q6XVW8, B5RDL8, P40290, Q7DB71, P74857, F8KX49, and P26465
for Spa47, InvC, YscN, EscN, SsaN, CdsN, and FliI, respectively
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(Figure 1C). Site 1, however, shows full conservation of the identified

interactions shown in Figure 1 may play important roles in forming

glutamate, but the arginines in Spa47 are both only conserved in the

and/or stabilizing Spa47 homo-oligomers. Size exclusion chromatogra-

T3SS ATPases InvC from Salmonella and YscN from Yersinia.

phy has been a valuable tool in characterizing Spa47 oligomerization
and was used here to determine the effect of mutating residues

3.2 | Engineered Spa47 site 1 and site 2 mutants
maintain overall structural integrity

within Site 1 and Site 2 to either alanine or to an opposite charged
residue (Figure 3). While mutating E267 within Site 1 to either alanine or arginine has no effect on oligomerization, mutating either

The N-terminal 79 residues were removed from each of the Spa47 pro-

R271 or R272 to glutamate significantly reduces the ability for the

teins to promote crystallization, resulting in 1.85 - 3.00 Å structures for

mutant to form stable oligomers (Figure 3A). Mutating either R271

10 of the 13 engineered Spa47 mutants (Supplementary Table S1 and

or R272 to alanine, however, eliminates oligomer formation alto-

Supplementary Figure S1). Each of the determined structures closely

gether. Looking at the highly conserved Site 2 shows that mutations

resemble the wild-type Spa47 structure, with Cα RMSD values ranging

to R189 and E287 reduce oligomerization, while all tested mutations

from 0.31 to 0.45 Å (Figure 2 and Supplementary Figure S1). Thus, the

targeting R191 abolished Spa47 oligomerization (Figure 3B), con-

mutations in the ten crystallized constructs do not appear to impact the

firming that the predicted Site 2 residues all play an important role in

local or global protein structures, suggesting that changes observed in

Spa47 oligomerization.

Spa47 activity, oligomer formation, and Shigella virulence phenotype
(described below) are due to changes in sidechain characteristics.

3.4 | Identified interfacial Spa47 residues influence
ATPase activity

3.3 | Identified Spa47 residues are critical for proper
oligomer formation

We have previously shown that stable Spa47 oligomers exhibit signifi-

Spa47 oligomerization is essential for ATPase activity and Shigella viru-

Spa47 due to the contribution of active site residues from adjacent

lence, therefore, it was hypothesized that the predicted intermolecular

protomers upon oligomerization.15 It seems that transient oligomeri-

cantly enhanced ATPase activity compared to isolated monomeric

zation accounts for the low level activity observed for isolated Spa47
monomers, likely utilizing an identical hydrolysis mechanism, but now
relying on the formation of a short-lived productive Spa47X/ATP complex. The effect of each of the engineered Site 1 and Site 2 mutations
on Spa47 ATPase activity was determined using a radioactive α-32PATP multiple time point activity assay (Figure 4). The activity results
show that the full-length wild-type monomeric and oligomeric Spa47
species behaved as previously reported,15 hydrolyzing ATP at rates of
0.20 ± 0.08 (μmol ADP/min)/mg Spa47 and 1.26 ± 0.22 (μmol
ADP/min)/mg Spa47, respectively. All tested mutations within Site
2 (R189, R191, R189/R191, and E287) abolished ATPase activity
regardless of ability to form stable oligomeric species. Interestingly,
mutations to the less conserved Site 1 residues, including E267, R271,
and R272, had a wider range of effects on the ability of Spa47 to
hydrolyze ATP and did not fully eliminate activity of any of the constructs. The alanine and arginine mutations to E267 both maintained
the ability to form stable oligomers, however, the mutated oligomers
exhibited ATPase activity levels similar to the respective monomers,
suggesting that E267 is not essential for stable oligomer formation,
but is perhaps necessary for stabilizing the protomer interface to support proper Spa47 ATPase activity. While the R271A and R272A Site
2 mutants both eliminated oligomerization, the monomers continued
to function at levels similar to the wild-type monomer (0.20 ± 0.04
(μmol ADP/min)/mg Spa47 and 0.33 ± 0.16 (μmol ADP/min)/mg
F I G U R E 2 High-resolution crystal structures of engineered Spa47
oligomerization mutants. Alignment of the previously solved wild-type
Spa47Δ1–79 structure (gray, PDB ID 5SWJ) to each of the ten
Spa47Δ1–79 point mutant structures solved in this study (structure
coloration is consistent with that used in Supplementary Figure S1)
[Color figure can be viewed at wileyonlinelibrary.com]

Spa47, respectively). The R271E mutant maintained wild-type monomer ATPase levels but attenuated oligomer activity, while the R272E
mutation surprisingly maintained wild-type levels for both monomeric
and oligomeric species (0.31 ± 0.22 (μmol ADP/min)/mg Spa47 and
1.02 ± 0.28 (μmol ADP/min)/mg Spa47, respectively).
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F I G U R E 3 Engineered Spa47 mutations negatively impact homooligomer formation. Size-exclusion chromatography analysis of purified Site
1 (A) and Site 2 (B) Spa47 mutants. The chromatograms from each Spa47 mutant are normalized to the A280 absorbance of the wild-type Spa47
monomer peak eluting at approximately 79 mL. The chromatograms have been further divided into those resulting in detectable levels of Spa47
oligomer formation (top) and those resulting from mutations that eliminated oligomerization (bottom). The void volume (Vo) of the column is
39.8 mL and is located with an arrow [Color figure can be viewed at wileyonlinelibrary.com]

3.5 | Predicted interfacial Spa47 residues support
overall Shigella virulence phenotype
Insertion of the T3SS translocator tip proteins IpaB and IpaC into the
host cell membrane forms the translocon pore and ultimately allows
secretion of effector proteins into eukaryotic host cell cytoplasm.29-32
Secretion of these effectors into the host cell supports invasion of the
infected host cell, escape from the resulting vacuole, and evasion of host
immune responses.4,33,34 To better understand the molecular details of
Spa47-mediated Shigella virulence, the effect of the engineered Spa47

wild-type Spa47, suggesting that additional interactions provided within
the T3SA sorting platform must partially mitigate the effects of these
mutations in vivo. Shigella expressing the Spa47 Site 1 mutations E267A,
E267R, and R271A showed at or near wild-type levels of hemolysis
(116 ± 12%, 108 ± 8%, and 91 ± 19%, respectively) and invasion
(66 ± 23%, 54 ± 7%, and 92 ± 15%, respectively). Despite forming only
monomers in vitro, the R272A mutant supported 32 ± 7% invasion and
18 ± 6% hemolysis phenotypes, respectively. The R271E and R272E
mutants both resulted in severely attenuated levels of both invasion and

Site 1 and Site 2 mutations on Shigella virulence phenotype were tested

hemolysis, despite robust in vitro ATPase activity profiles for both mono-

using red blood cell hemolysis and gentamicin protection (cellular inva-

meric and oligomeric species.

sion) assays (Figure 5). With the exception of the R191E and E287A
mutations, each of the Site 2 mutations essentially abolished invasion
and hemolysis phenotype, consistent with the lack of in vitro ATPase
activity observed for these mutants (Figure 4). Surprisingly, even though
no ATPase activity was observed in vitro for the Spa47 R191E and

3.6 | IpaC secretion profiles provide insight into the
effects of engineered Spa47 mutations on T3SS
activity and Shigella virulence

E287A mutants, Shigella expressing these mutants exhibited moderate

While the specific mechanism remains unclear and somewhat contro-

invasion and hemolysis levels when compared to Shigella expressing

versial, Spa47 catalyzed ATP hydrolysis is required for efficient

938

F I G U R E 4 Kinetic analysis of ATP hydrolysis by each of the
engineered Spa47 constructs used in this study. Isolated wild-type
monomeric and oligomeric Spa47 are both active, with the oligomeric
species (black bar) resulting in a significantly enhanced rate of
hydrolysis compared to the monomeric form (gray bar). ATP
hydrolysis rates were additionally determined for isolated monomeric
and oligomeric forms (when available) for all engineered Site 1 and
Site 2 Spa47 mutants. Each data set represents the mean ± S.D. of
three independent kinetic experiments from two independent protein
preparations. (*) Indicates a statistical significance compared to the
appropriate oligomer state of wild-type Spa47 (one-way ANOVA
followed by a Dunnett's post test, P ≤ 0.05))

protein secretion through the associated needle and tip complex of the
Shigella T3SA. To determine the effect that the tested Spa47 mutations
had on the ability of Shigella to actively secrete effector proteins
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F I G U R E 5 Effect of engineered Spa47 salt bridge mutations on
Shigella virulence phenotype. The ability of the Shigella mutants to
invade eukaryotic host cells was measured by a standard gentamicin
protection assay. Invasion results (shown in black) are presented as
the percentage of invasion by a S. flexneri strain expressing wild-type
Spa47 and represent at least three independent experimental data
sets spanning two biological replicates. The impact of each Spa47
mutant has on Shigella's ability to disrupt phospholipid membranes
was examined using a hemolysis assay that quantifies released
hemoglobin following incubation of red blood cells with the described
Shigella mutants. Hemolysis results (shown in gray) are presented as a
percentage of the hemoglobin released by the S. flexneri strain
expressing wild-type Spa47 and result from at least six experiments
spanning two biological replicates. Invasion and hemolysis data are
both presented as mean values ± S.D. (*) Indicates statistical
significance compared to the wild-type Spa47 strain (one-way
ANOVA followed by a Dunnett's posttest, P ≤ 0.05))

through the T3SA, the levels of the secreted Shigella translocator protein IpaC were quantified following Congo Red activation of Shigella

several of the identified Spa47 Site 1 and Site 2 residues are essential

strains expressing each of the engineered Spa47 Site 1 and Site

for proper T3SS effector secretion and Shigella virulence.

2 mutants (Figure 6). Consistent with the hemolysis and invasion results
in Figure 5, the Spa47 Site 2 mutants significantly attenuated or eliminated IpaC secretion through the apparatus. The Shigella strains

4 | DISCUSSION

expressing Spa47 R191E and Spa47 E287A resulted in low, but detectable secretion levels of IpaC (11% ± 2% and 27% ± 6%, respectively).
Low levels of secreted IpaC were also observed for Shigella expressing
the Site 1 Spa47 mutants R271E, R272A, and R272E, again tracking

T3SS are critical virulence factors for a broad class of Gram-negative
pathogens, driving significant efforts over the past three decades to
uncover their structure, function, activation mechanism(s), and regulatory

well with the hemolysis and invasion phenotypes observed for these

pathway(s). One mechanistic detail of particular interest is uncovering

strains (Figure 5). Wild-type levels of IpaC secretion were observed for

specifically where the energy comes from that supports protein unfolding

the Shigella strain expressing the Spa47 R271A mutant while the

and secretion through the narrow apparatus needle. Work primarily

E267A and E267R mutations unexpectedly increased IpaC secretion

focusing on the flagellar T3SS suggests that secretion is driven by proton

levels to 233% ± 48% and 146% ± 15% of wild-type. These enhanced

motive force (PMF) that is coupled to protein secretion through an export

secretion levels likely support the robust invasion and hemolysis pheno-

gate in the basal body that acts as a proton/protein antiporter.35-37 While

types of these mutants despite low level ATPase activity observed for

the influence of an electrochemical gradient can certainly not be ruled

the purified mutant oligomers in vitro. With the IpaC secretion profiles

out, expression of non-catalytic Spa47 mutants eliminates effector secre-

in good agreement with the observed Shigella virulence phenotypes, it

tion and pathogen virulence in Shigella, suggesting that at least Shigella

seems clear that the ability of the Shigella strains to secrete protein

type three secretion is either independent of PMF and solely reliant on

effectors is directly correlated with Spa47 ATPase activity and that

ATP hydrolysis, or more likely that the effects of ATP hydrolysis and
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in vivo.10,14 Regardless, the importance of oligomerization in activation
of T3SS ATPases such as Spa47 underscores the need to better understand not only the specific mechanism of ATP hydrolysis, but also the
molecular basis of oligomerization itself.
The work presented here provides insight into Spa47 oligomer
formation by identifying two independent sites at the interface of
Spa47 protomers that support stable Spa47 oligomer formation, enzymatic activation of isolated Spa47, protein secretion through the
T3SA, and overall Shigella virulence. Mutating R271 or R272 from Site
1 to alanine or R191 from Site 2 to either alanine or glutamate
prevented stable Spa47 oligomerization altogether (Figure 3 and Supplementary Table S2). Interestingly, none of the tested mutations to
E267 (Site 1) affected oligomerization while the R271E and R272E
reduced, but did not eliminate, Spa47 oligomer formation. All of the
tested mutations to Site 2 residues, on the other hand, reduced or
eliminated oligomerization, suggesting that while both identified sites
play important roles in Spa47 oligomerization, Site 2 has a stronger
influence, consistent with the fact that each of the identified Site
2 residues are fully conserved among several well-studied T3SS
ATPases (Figure 1C). The influence of the tested Site 1 and Site
2 mutations on enzyme function was demonstrated with an ATPase
activity assay, where the mutants targeting Site 1 residues exhibited
varying degrees of ATPase activity while ATPase activity of each of
the Site 2 mutants was essentially eliminated. In vivo testing of ShiF I G U R E 6 Immunoblot analysis of Congo Red-induced T3SS
secretion profiles for engineered Spa47 mutant Shigella strains. The
levels of IpaC actively secreted following Congo Red induction were
compared for Shigella strains expressing the Spa47 salt bridge mutants
as well as positive and negative controls expressing wild-type Spa47
and a Spa47 null strain, respectively. A, Actively secreted IpaC was
detected by Western blot and levels compared using fluorescence
densitometry. The cytoplasmic enzyme GAPDH was observed in the
whole cell extracts (WCE) but not in the supernatant containing the
secreted IpaC protein. B, The secreted IpaC levels are reported
relative to a S. flexneri strain expressing wild-type Spa47. The
reported values represent the means ± SD from three independent
analyses and two biological replicates. (*) indicates statistical
significance compared to the wild-type Spa47 strain (one-way
ANOVA followed by a Dunnett's posttest, P ≤ 0.05))
PMF are synergistic.15,16 What is clear, however, is that the Shigella T3SS
relies on Spa47 catalyzed ATP hydrolysis, suggesting that Spa47 may be
involved with in vivo activation and regulation of the Shigella T3SS and is
an attractive target for the development of non-antibiotic small molecule
therapeutics.

gella virulence and T3SS-mediated effector secretion also showed the
strongest influence by Site 2 mutants, with six of the eight tested
Spa47 Site 2 mutants unable to disrupt red blood cell membranes or
infect cultured eukaryotic cells. Not surprisingly, these virulence phenotypes correlate quite well with T3SS effector protein (IpaC) secretion
levels, showing that protein secretion is linked to Spa47 catalyzed ATP
hydrolysis and that Shigella virulence is driven by protein secretion
through the T3SA. Surprisingly, despite being ATPase inactive
in vitro, the Site 2 Spa47 R191E and E287A mutants exhibited modest, yet robust, invasion, hemolysis, and effector secretion capabilities, suggesting that additional interactions within the T3SA can
overcome the effects of these mutations and support Spa47 oligomerization/activation in vivo. While the data reported in this study
clearly show that the identified Spa47 interfaces are involved in
supporting oligomerization and ATPase activity, specific molecular
insight into the intermolecular interactions involving the Site 1 and
Site 2 residues was unavailable until Majewski and colleagues published a 3.3 Å cryo-EM structure of the E. coli homo-hexameric T3SS
ATPase EscN during the preparation of this manuscript.44
The cryo-EM structure of EscN is currently the only high-

Like the catalytic hetero-hexameric F1 and V1 ATPases, activation

resolution structure available for an activated homo-hexameric

of T3SS ATPases requires oligomerization to complete interfacial active

T3SS ATPase, providing valuable insight into the conformational

sites in the complex. In contrast to the presumably more evolved

changes and intermolecular interactions responsible for ATP hydro-

hetero-hexameric F1 and V1 ATPases, however, all enzymatically char-

lysis and a structural rationale for the effects observed in the

acterized examples of T3SS ATPases form homo-oligomers.16,38-43

Spa47 mutants engineered in this study. Specifically, the homo-

In vitro studies of T3SS ATPases have identified active complexes rang-

hexameric EscN structure includes the central stalk protein EscO as

ing from homo-trimers to homo-dodecamers, though cryo-electron

well as the transition state analog Mg2+ ADP-AlF3 in four of the

imaging of T3SSs from Shigella and Salmonella both suggest that homo-

six EscN protomer interfaces, displaying conformational changes

hexameric T3SS ATPases reside at the base of the apparatus

reminiscent of those supporting ATP synthesis/hydrolysis in rotary
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F I G U R E 7 Conserved EscN Site 2 residues provide critical noncovalent intermolecular interactions and insight into Spa47 oligomerization
and activation. A stereo image of the aligned EscN active sites and Site 2 residues from an apo (gray) and nucleotide-bound (cyan) protomer
interface was generated from the published cryo-EM EscN homo-hexameric structure (PDB ID 6NJP).44 Significant structural rearrangement
within the nucleotide-bound interface (cyan) favorably positions the conserved Site 2 residues for intermolecular hydrogen bonding across the
protomer interface (dashed lines) and positions arginine 207 to stabilize the substrate and support catalysis. All of the residues involved in this
EscN intermolecular hydrogen bonding network are conserved in Spa47 and are likely responsible for the altered Spa47 oligomerization
characteristics and Shigella phenotypes observed for Spa47 Site 2 mutants [Color figure can be viewed at wileyonlinelibrary.com]

F- and V-type hetero-hexameric ATPases.44 Superposition of nucleotide-

understanding the influences of the identified residues on Spa47

free and nucleotide bound active sites reveals significant conformational

activity and type three secretion will likely require a series of bio-

rearrangements at the protomer interface (Figure 7, stereo image). The

chemical and biophysical studies spanning T3SS ATPases from other

transition from nucleotide-free to nucleotide-bound states involves a

pathogens as well as structural and perhaps single molecule fluores-

shift of up to 7 Å between individual monomers at the interface. The shift

cence studies. Predicting and characterizing the influence of the

engages an intermolecular hydrogen bonding network that includes Site

tested mutations in this study, however, begins to paint a picture of

2 residues. Two of these hydrogen bonds are observed between the

how Spa47 is activated and uncovers much needed targets for non-

EscN R209 (R191 in Spa47) and D340 (D324 in Spa47) sidechains, and

antibiotic small molecule therapeutics that should inhibit Spa47

between the sidechain of E304 (E287 in Spa47) and the backbone of

ATPase activity and may be effective in targeting the conserved sites

G208 (G190 in Spa47). As a consequence, R207 (R189 in Spa47) is posi-

of additional T3SS ATPases such as EscN.

tioned to coordinate the gamma phosphate of ATP, presumably facilitating phosphate hydrolysis. This is in good agreement with the results
presented here as all of the tested mutations to Spa47 R189 lacked
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